Cardiac affection in type 1 diabetic patients in relation to omentin

Open Access Macedonian Journal of Medical Sciences

Volumn 3, Issue 4, 2015, Pages 699-704

  Abd El Dayem, Soha M ^a   Battah, Ahmed A ^b   El Shehaby, Amal ^c  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

24 hr holter; Autonomic neuropathy; Cardiovascular; Coronary calcification; Type 1 diabetic patient

Indexed keywords

ADIPOCYTOKINE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMENTIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MONITORING; CARDIAC AUTONOMIC NEUROPATHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FUNCTION; HEART RATE VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOLTER MONITORING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OBSERVATIONAL STUDY; URINALYSIS;

EID: 85027416483     PISSN: None     EISSN: 18579655     Source Type: Journal    
DOI: 10.3889/oamjms.2015.132     Document Type: Article

References (44)

1. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548–2556. http://dx.doi.org/10.1210/jc.2004-0395 PMid:15181022
2. Fukuhara AM, Matsuda M, Nishizawa K, Segawa M, Tanaka K, Kishimoto Y, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426–430. http://dx.doi.org/10.1126/science.1097243 PMid:15604363
3. Heidemann C, Sun Q, van Dam RM, Meigs JB, Zhang C, Tworoger SS, et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med. 2008;149(5):307–316. http://dx.doi.org/10.7326/0003-4819-149-5-200809020-00005 PMid:18765700 PMCid:PMC3874083
4. Wannamethee S.G., Lowe G.D.O., Rumley A, Cherry L, Whincup PH, Sattar N, Adipokines and risk of type 2 diabetes in older men. Diabetes Care. 2007;30:1200–1205. http://dx.doi.org/10.2337/dc06-2416 PMid:17322479
5. Ahima RS, Lazar MA, Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol. 2008;22: 1023–1031. http://dx.doi.org/10.1210/me.2007-0529PMid:18202144 PMCid:PMC2366188
6. Hivert MF, Sullivan LM, Fox CS, Nathan DM, D’Agostino RB, Wilson WF, et al. Associations of adiponectin, resistin, and tumor necrosis factor-a with insulin resistance. J Clin Endocrinol Metab. 2008;93:3165–3172. http://dx.doi.org/10.1210/jc.2008-0425 PMid:18492747 PMCid:PMC2515087
7. Lorenzo M, Ferna’ndez-Veledo S, Vila-Bedmar R, Garcia- Guerra L, De Alvaro CDC, Nieto-Vazquez I. Insulin resistance induced by tumor necrosis factor-a in myocytes and brown adipocyte. J Anim Sci. 2008;86:E94–E104. http://dx.doi.org/10.2527/jas.2007-0462 PMid:17940160
8. Yang R, Xu A, Pray J, Hu H, Jadhao S, Hansen B, et al. Cloning of omentin, a new adipocytokine from omental fat tissue in humans. Diabetes 2003;52(supplement 1):1-A730.
9. Fu M, Gong DW, Damcott C, Sabra M, Yang RZ, Pollin TI, et al. Systematic analysis of omentin- 1 and omentin -2 on 1q23 as candidate genes for type 2 diabetes in the old order amish. Diabetes. 2004;53:A59.
10. Jean PSt, Husueh WC, Mitchell B, Ehm M, Wanger M, Burns D, et al. Association between diabetes, obesity, glucose and insulin levels in the old older amish and SNPs on 1q21–23. Am J Hum Genet. 2000;67:332–337.
11. Xiang K, Wang Y, Zheng T, Jia W, Li J, Chen L, et al. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21–q23 and chromosome 1q21– q24. Diabetes. 2004;53:228–234. http://dx.doi.org/10.2337/diabetes.53.1.228 PMid:14693720
12. Vionnet N, Hani ElH, Dupont S, Gallina S, Francke S, Dotte S, et al. Genome wide search for type 2 diabetes susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21–q24. Am J Hum Genet. 2000;67:1470–1480. http://dx.doi.org/10.1086/316887PMid:11067779 PMCid:PMC1287924
13. de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007;56:1655–1661. http://dx.doi.org/10.2337/db06-1506 PMid:17329619
14. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab. 2006;290:E1253–E1261. http://dx.doi.org/10.1152/ajpendo.00572.2004 PMid:16531507
15. Pan HY, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Research and Clinical Practice. 2010;88: 29–33. http://dx.doi.org/10.1016/j.diabres.2010.01.013 PMid:20129687
16. Tanner JM, Hiernaux J, Jarman S. Growth and physical studies. In: Weiner JS, Lourie JA, editors. Human biology: a guide to field methods. Oxford: Blackwell Scientific Publ., 1969:pp. 3–41.
17. Cameron N. The methods of auxological anthropology. In: Falkner F, Tanner JM, editors. Human growth 3 Methodology. New York: Plenum Press, 1986:pp. 3–46. PMid:3956717
18. Flegg HM. An investigation for the determination of serum cholesterol by an enzymatic method. Ann Clin Biochem. 1973;10:79–84. http://dx.doi.org/10.1177/000456327301000125
19. Marques-Vidal P, Ferrario M, Kuulasmaa K, Grafnetter D, Moltchanov V, for the WHO MONICA Project. Quality assessment of data on HDL cholesterol in the WHO MONICA Project, 1999. Available at: URL: http://www.thl.fi/publications/monica/hdl/hdlqa.htm URN:NBN:fi-fe19991137.
20. Danilova LA, Lopatina NI. Colorimetric method of determining glycosylated haemoglobin. Lab Delo. 1986;5:282–3.
21. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Eng J Med. 1984;310:356–60. http://dx.doi.org/10.1056/NEJM198402093100605 PMid:6690964
22. Craig WY, Poulin SE, Nelson CP, Ritchie RF. An ELISA method for detection and quantitation of IgG antibody against oxidized low density lipoprotein: the effect of blocking buffer and the method of data expression on experimental findings. Clin Chem. 1994;40:882–8. PMid:8087982
23. Chiat A. Methods for assessing lipid and lipoprotein oxidation. Curr Opin Lipidol. 1992;3:389–94. http://dx.doi.org/10.1097/00041433-199212000-00007
24. Welch’s PD. The Use of Fast Fourier Transform for the Estimation of Power Spectra: A Method Based on Time Averaging Over Short, Modified Periodograms. IEEE Transactions on Audio and Electroacoustics. 1967;15:70-73. http://dx.doi.org/10.1109/TAU.1967.1161901
25. Cowan MJ. Measurement of heart rate variability. Western Journal of Nursing Research. 1995;17(1):32–48. 101–11.
26. Faulkner MS, Quinn L, Fritschi C. Microalbuminuria and Heart Rate Variability in Adolescents with Diabetes. J Pediatr Health Care. 2010;24(1):34-47. http://dx.doi.org/10.1016/j.pedhc.2009.01.002 PMid:20122476 PMCid:PMC2819478
27. Kleiger RE, Miller JP, Bigger JTJr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. American Journal of Cardiology. 1987;59(4):256–62. http://dx.doi.org/10.1016/0002-9149(87)90795-8
28. Kleiger RE, Stein PK, Bosner MS, Rottman JN. Time domain measurements of heart rate variability. Cardiol Clin. 1992;10:487-98. PMid:1504980
29. Bazett HC. An analysis of the time relationships of the electrocardiograms. Annals of Noninvasive Electrocardiology. 1997;2(2): 177–194. http://dx.doi.org/10.1111/j.1542-474X.1997.tb00325.x
30. Boysen A, Lewin MA, Hecker W, Leichter HE, Uhlemann F. Autonomic function testing in children and adolescents with diabetes mellitus. Pediatric Diabetes. 2007;8(5):261–64. http://dx.doi.org/10.1111/j.1399-5448.2007.00254.x PMid:17850468
31. Faulkner MS, Hathaway DK, Milstead EJ, Burghen GA. Heart rate variability in adolescents and adults with T1DM. Nursing Research. 2001;50(2):95–104. http://dx.doi.org/10.1097/00006199-200103000-00005 PMid:11302298
32. Faulkner MS, Quinn L, Rimmer JH, Rich BH. Cardiovascular endurance and heart rate variability in adolescents with type 1 or type 2 diabetes. Biological Research for Nursing. 2005;7(1):16–29. http://dx.doi.org/10.1177/1099800405275202 PMid:15920000 PMCid:PMC1447599
33. Chen HS, Wu TE, Jap TS, Lee SH, Wang ML, Lu RA, et al. Decrease heart rate variability but preserve postural blood pressure change in type 2 diabetes with microalbuminuria. J. Clin Med Assoc. 2006;69(6):254–58. http://dx.doi.org/10.1016/S1726-4901(09)70252-7
34. Gandhi RA, Marques JL, Selvarajah D, Emary C, Tesfaye S. Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy. Diabetes Care. 2010;33(7):1585–90. http://dx.doi.org/10.2337/dc09-2314 PMid:20587724 PMCid:PMC2890363
35. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab. 2008; 93:578-583. http://dx.doi.org/10.1210/jc.2007-2185 PMid:18029454 PMCid:PMC2243229
36. Bingley PJ, Mahon JL, Gale EA, European Nicotinamide Diabetes Intervention Trial Group. Insulin Resistance and Progression to Type 1 Diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care. 2008; 31:146-150. http://dx.doi.org/10.2337/dc07-0103 PMid:17959864
37. Tan BK, Adya R and Randeva HS. Omentin: A novel link between inflammation, diabesity, and cardiovascular Disease. Trends Cardiovasc Med. 2010;20:143-148. http://dx.doi.org/10.1016/j.tcm.2010.12.002 PMid:21742269
38. Cai RC, Wei L, DI JZ, Yu HY, Bao YQ, Jia WP. Expression of omentin in adipose tissues in obese and type 2 diabetic patients. Zhonghua Yi Xue Za Zhi. 2009;89:381-384. PMid:19567114
39. Pan HY, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract. 2010;88:29-33. http://dx.doi.org/10.1016/j.diabres.2010.01.013 PMid:20129687
40. Tan BK, Adya R, Farhatullah S, Lewandowski KC, O’Hare P, Lehnert H, et al. Omentin-1, a novel adipokine, is decreased in overweight insulin resistant women with the polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes. 2008;57:801-808. http://dx.doi.org/10.2337/db07-0990 PMid:18174521
41. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153:907-917. http://dx.doi.org/10.1016/j.ahj.2007.03.019 PMid:17540190
42. Tan BK, Pua S, Syed F, Lewandowski KC, O’Hare JP, Randeva HS. Decreased plasma omentin-1 levels in type 1 diabetes mellitus. Diabet Med. 2008;25(10):1254–1255. http://dx.doi.org/10.1111/j.1464-5491.2008.02568.x PMid:19046210
43. Krupinski J, Font A, Luque A, et al. Angiogenesis and inflammation in carotid atherosclerosis. Front Biosci. 2008; 13:6472-6482. http://dx.doi.org/10.2741/3167 PMid:18508673
44. Leal VO, Mafra D. Adipokines in obesity. Clinica Chimica Acta. 2013;419:87–94. http://dx.doi.org/10.1016/j.cca.2013.02.003 PMid:23422739